PTC Therapeutics

Email Page

Print Page

Glossary

Site Map

Get Flash

PTC124 is a novel, orally administered, small-molecule, investigational new drug for the treatment of genetic disorders resulting from nonsense mutations.
Read more »

> PTC124 Summary

> Frequently Asked Questions

> Contact us to submit questions or join our update list

PTC is a committed group of people that has a passion for science and a desire to succeed. Learn more »

Click below for more information on current clinical trials.

> PTC124 Duchenne/Becker Muscular Dystrophy

> PTC299 for Metastatic Breast Cancer

4/23/2008 - PTC Therapeutics Announces Initiation of Phase 2b Registration-Directed Clinical Trial of PTC124 in Duchenne/Becker Muscular Dystrophy
Read more »
More PTC news »

Find out what meetings PTC Therapeutics will be attending to learn more about our company and our technology.